Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Healthcare
Create a narrative
Hyperfine Community
NasdaqGM:HYPR Community
3
Narratives
written by author
0
Comments
on narratives written by author
6
Fair Values set
on narratives written by author
Community Investing Ideas
Hyperfine
Popular
Undervalued
Overvalued
Hyperfine
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
FDA Clearances And Demographics Will Create Opportunity Despite Valuation Risks
Key Takeaways Valuation relies on aggressive assumptions of rapid adoption, strong pricing power, and seamless international expansion amid demographic and healthcare trends. Sustained growth expectations are vulnerable to delays, competitive innovation, regulatory headwinds, or setbacks in technological integration and payer acceptance.
View narrative
US$1.19
FV
16.5% overvalued
intrinsic discount
28.28%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
Updated
narrative
Hyperfine
AN
AnalystLowTarget
Consensus Narrative from 3 Analysts
Supply Disruptions And Delayed Adoption Will Undermine Long-Term Outlook
Key Takeaways Weak differentiation, high costs, and market resistance threaten sustained adoption, limiting pricing power, recurring revenue, and delaying profitability. Supply chain risks, regulatory challenges, and competition from alternative technologies could further constrain market size, margin recovery, and overall earnings growth.
View narrative
US$0.68
FV
104.4% overvalued
intrinsic discount
30.40%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Hyperfine
AN
AnalystHighTarget
Consensus Narrative from 3 Analysts
Global Aging And Telemedicine Will Drive Portable MRI Adoption
Key Takeaways Rapid clinical adoption, global expansion, and unique use-cases position Swoop for outsized revenue growth and transformative market share gains over traditional MRI. Strong network effects, recurring high-margin revenue, and scalable operations suggest substantial improvement in operating margins and long-term profitability.
View narrative
US$1.50
FV
7.3% undervalued
intrinsic discount
25.90%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Your Valuation for
HYPR
HYPR
Hyperfine
Your Fair Value
US$
Current Price
US$1.39
93.1% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-89m
29m
2015
2018
2021
2024
2025
2027
2030
Revenue US$29.0m
Earnings US$4.2m
Advanced
Set Fair Value